News
-
-
-
-
-
-
PRESS RELEASE
Jaguar Health Announces Abstract Submission for Preliminary Data from US Investigator-Initiated Trial of Crofelemer in Adult Patients with Short Bowel Syndrome with Intestinal Failure (SBS-IF)
Jaguar Health announces submission of abstract detailing preliminary findings from clinical trial on a novel oral liquid formulation of crofelemer for SBS-IF patients, supporting the focus on reducing PS needs in intestinal failure patients -
-
-
-
PRESS RELEASE
HighCo : Transactions sur actions propres du 08 au 12 décembre 2025
Déclaration des transactions sur actions propres réalisées par HighCo du 08 au 12 décembre 2025. Expert en marketing et communication, HighCo fait partie des indices CAC® Small, CAC® Mid&Small, CAC® All-Tradable, Euronext® Tech Croissance et Enternext® PEA-PME 150 index